INVEGA TRINZA 175mg/0.875mL ProlongedRelease Suspension for Intramuscular Injection
Category: Drug Info
Specifications
Details
Manufacturer
JANSSEN PHARMACEUTICA N.V.(BELGIUM)
Registraction Number
MAL20046067AZ
Content:
INVEGA TRINZA (Paliperidone Palmitate) 175mg/0.875mL Prolonged-Release Suspension for Intramuscular Injection contains the active ingredient paliperidone palmitate. Each prefilled syringe contains 175 mg of paliperidone palmitate in 0.875 mL of suspension.
Indications:
INVEGA TRINZA is used for the treatment of:
Schizophrenia: In patients who have been adequately treated with INVEGA SUSTENNA (1-month paliperidone palmitate) for at least four months.
Instructions:
Dosage: The medication should be administered once every 3 months.
Administration:
-Preparation: Shake the syringe vigorously for at least 15 seconds to ensure a homogeneous suspension.
-Injection: Administer the injection intramuscularly into the deltoid or gluteal muscle. The needle selection depends on the patient's weight and injection site:
-For deltoid injection: Use a 22G x 1" needle for patients weighing less than 90 kg, and a 22G x 1½" needle for patients weighing 90 kg or more.
-For gluteal injection: Use a 22G x 1½" needle regardless of the patient's weight.
-Procedure: Inject slowly, deep into the muscle, taking care to avoid injection into a blood vessel. Do not divide the dose into multiple injections.
View more about INVEGA TRINZA 175mg/0.875mL ProlongedRelease Suspension for Intramuscular Injection on main site